HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chris Moyses Selected Research

OGT 719

1/2004A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chris Moyses Research Topics

Disease

1Hepatocellular Carcinoma (Hepatoma)
01/2004
1Liver Neoplasms (Liver Cancer)
01/2004
1Gaucher Disease (Gaucher's Disease)
05/2003

Drug/Important Bio-Agent (IBA)

1OGT 719IBA
01/2004
1Asialoglycoprotein ReceptorIBA
01/2004
1miglustat (Zavesca)FDA Link
05/2003
1Glucosylceramides (Glucocerebrosides)IBA
05/2003
1Glucosylceramidase (Glucocerebrosidase)IBA
05/2003
1EnzymesIBA
05/2003

Therapy/Procedure

1Therapeutics
05/2003
1Oral Administration
05/2003